Selected Aspects of Angiogensis in Haematological Malignancies

[1] ABOUDOLA S, KINI AR., Angiogenesis in lymphoproliferative disorders: a therapeutic target? Curr Opin Hematol 2005; 12(4): 279-83.10.1097/01.moh.0000168521.76120.7b15928484Open DOISearch in Google Scholar

[2] ACHEN MG, GAD JM, STACKER SA, WILKS AF. Placenta growth factor and vascular endothelial growth factor are co-expressed during early embryonic development. Growth Factors 1997; 15(1): 69-80.10.3109/089771997090021139401819Open DOISearch in Google Scholar

[3] AGUAYO A, KANTARJIAN H, MANSHOURI T, GIDEL C, ESTEY E, THOMAS D, KOLLER C, ESTROV Z, O'BRIEN S, KEATING M, FREIREICH E, ALBITAR M. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96(6): 2240-2245.10.1182/blood.V96.6.2240Search in Google Scholar

[4] AVRAMIS IA, PANOSYAN EH, DOREY F, HOLCENBERG JS, AVRAMIS VI. Children's Oncology Group., Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: a report from Children's Oncology Group Study CCG-1962. Clin Cancer Res 2006; 12(23): 6978-6984. 10.1158/1078-0432.CCR-06-114017145817Open DOISearch in Google Scholar

[5] BACHELDER RE, CRAGO A, CHUNG J, WENDT MA, SHAW LM, ROBINSON G, MERCURIO AM. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res 2001; 61(15): 5736-5740.Search in Google Scholar

[6] BATES DO, HILLMAN NJ, WILLIAMS B, NEAL CR, POCOCK TM. Regulation of microvascular permeability by vascular endothelial growth factors. J Anat 2002; (6): 581-97.10.1046/j.1469-7580.2002.00066.x157075112162726Open DOISearch in Google Scholar

[7] BATTEGAY EJ. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 1995; 73(7): 333-346.10.1007/BF001928858520966Search in Google Scholar

[8] BELLÓN T, CORBÍ A, LASTRES P, CALÉS C, CEBRIÁN M, VERA S, CHEIFETZ S, MASSAGUE J, LETARTE M, BERNABÉU C. Identification and expression of two forms of the human transforming growth factor-beta-binding protein endoglin with distinct cytoplasmic regions. Eur J Immunol 1993; 23(9): 2340-2345.10.1002/eji.18302309438370410Open DOISearch in Google Scholar

[9] BENJAMIN LE, KESHET E. Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal. Proc Natl Acad Sci USA 1997; 94(16): 8761-876610.1073/pnas.94.16.8761231189238051Open DOISearch in Google Scholar

[10] BOGAR LJ, BARTULA LL, PARKMAN HP, MYERS SI. Enhanced bradykinin-stimulated prostaglandin release in the acutely inflamed guinea pig gallbladder is due to new synthesis of cyclooxygenase 1 and prostacyclin synthase. J Surg Res 1999; 84(1): 71-76.10.1006/jsre.1999.561210334892Search in Google Scholar

[11] BOULOUMIÉ A, DREXLER HC, LAFONTAN M, BUSSE R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 1998; 83(10): 1059-1066.10.1161/01.RES.83.10.10599815153Open DOISearch in Google Scholar

[12] BREIER G. Angiogenesis in embryonic development--a review. Placenta 2000; 21 Suppl A: S11-15.10.1053/plac.1999.0525Open DOISearch in Google Scholar

[13] BROOKS PC, STRÖMBLAD S, KLEMKE R, VISSCHER D, SARKAR FH, CHERESH DA. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 1995; 96(4): 1815-1822.10.1172/JCI118227Open DOISearch in Google Scholar

[14] CARMELIET P. Angiogenesis in health and disease. Nat Med 2003; 9(6): 653-66010.1038/nm0603-653Open DOISearch in Google Scholar

[15] CARMELIET P, JAIN RK. Angiogenesis in cancer and other diseases. Nature 2000; 407(6801): 249-257.10.1038/35025220Search in Google Scholar

[16] CARMELIET P, MOONS L, LUTTUN A, VINCENTI V, COMPERNOLLE V, DE MOL M, WU Y, BONO F, DEVY L, BECK H, SCHOLZ D, ACKER T, DIPALMA T, DEWERCHIN M, NOEL A, STALMANS I, BARRA A, BLACHER S, VANDENDRIESSCHE T, PONTEN A, ERIKSSON U, PLATE KH, FOIDART JM, SCHAPER W, CHARNOCK-JONES DS, HICKLIN DJ, HERBERT JM, COLLEN D, PERSICO MG. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 2001; 7(5): 575-583. 10.1038/87904Open DOISearch in Google Scholar

[17] CHEIFETZ S, BELLÓN T, CALÉS C, VERA S, BERNABEU C, MASSAGUÉ J, LETARTE M. Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells. J Biol Chem 1992; 267(27): 19027-19030.10.1016/S0021-9258(18)41732-2Search in Google Scholar

[18] DALLAS NA, SAMUEL S, XIA L, FAN F, GRAY MJ, LIM SJ, ELLIS LM, Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res 2008; 14(7): 1931-1937.10.1158/1078-0432.CCR-07-447818381930Open DOISearch in Google Scholar

[19] DE BONT ES, NEEFJES VM, ROSATI S, VELLENGA E, KAMPS WA. New vessel formation and aberrant VEGF/VEGFR signaling in acute leukemia: does it matter? Leuk Lymphoma 2002; 43(10): 1901-1909.10.1080/104281902100001584412481883Open DOISearch in Google Scholar

[20] DÜWEL A, ELENO N, JERKIC M, AREVALO M, BOLAÑOS JP, BERNABEU C, LÓPEZNOVOA JM, Reduced tumor growth and angiogenesis in endoglin-haploinsufficient mice. Tumour Biol 2007; 28(1): 1-8.10.1159/00009704017108712Search in Google Scholar

[21] EGGERT A, IKEGAKI N, KWIATKOWSKI J, ZHAO H, BRODEUR GM, HIMELSTEIN BP, Highlevel expression of angiogenic factors is associated with advanced tumor stage in human neuroblastomas. Clin Cancer Res 2000; 6(5): 1900-1908.Search in Google Scholar

[22] ELICEIRI BP, CHERESH DA. The role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Invest 1999; 103(9): 1227-1230.10.1172/JCI686940836010225964Open DOISearch in Google Scholar

[23] FERRARA N, GERBER HP, LECOUTER J. The biology of VEGF and its receptors. Nat Med 2003; 9(6): 669-67610.1038/nm0603-669Open DOISearch in Google Scholar

[24] FOLKMAN J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1(1): 27-31.10.1038/nm0195-27Open DOISearch in Google Scholar

[25] FOLKMAN J. Tumor angiogenesis. Adv Cancer Res 1985; 43: 175-203.10.1016/S0065-230X(08)60946-XOpen DOISearch in Google Scholar

[26] FONSATTI E, DEL VECCHIO L, ALTOMONTE M, SIGALOTTI L, NICOTRA MR, CORAL S, NATALI PG, MAIO M. Endoglin: An accessory component of the TGF-beta-binding receptorcomplex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies. J Cell Physiol 2001; 188(1): 1-7.10.1002/jcp.1095Open DOISearch in Google Scholar

[27] FONSATTI E, JEKUNEN AP, KAIREMO KJ, CORAL S, SNELLMAN M, NICOTRA MR, NATALI PG, ALTOMONTE M, MAIO M. Endoglin is a suitable target for efficient imaging of solid tumors: in vivo evidence in a canine mammary carcinoma model. Clin Cancer Res 2000; 6(5): 2037-2043.Search in Google Scholar

[28] FOSS HD, ARAUJO I, DEMEL G, KLOTZBACH H, HUMMEL M, STEIN H. Expression of vascular endothelial growth factor in lymphomas and Castleman's disease. J Pathol 1997; 183(1): 44-50.10.1002/(SICI)1096-9896(199709)183:1<44::AID-PATH1103>3.0.CO;2-IOpen DOISearch in Google Scholar

[29] GERBER HP, VU TH, RYAN AM, KOWALSKI J, WERB Z. FERRARA N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 1999; 5(6): 623-628.10.1038/9467Search in Google Scholar

[30] GOUGOS A, LETARTE M. Identification of a human endothelial cell antigen with monoclonal antibody 44G4 produced against a pre-B leukemic cell line. J Immunol 1988; 141(6): 1925-1933.Search in Google Scholar

[31] GOUMANS MJ, LIU Z, TEN DIJKE P. TGF-beta signaling in vascular biology and dysfunction. Cell Res 2009; 19(1): 116-127.10.1038/cr.2008.326Open DOISearch in Google Scholar

[32] GUERRERO-ESTEO M, SANCHEZ-ELSNER T, LETAMENDIA A, BERNABEU C. Extracellular and cytoplasmic domains of endoglin interact with the transforming growth factor-beta receptors I and II. J Biol Chem 2002; 277(32): 29197-29209.10.1074/jbc.M111991200Search in Google Scholar

[33] HANAHAN D, FOLKMAN J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996; 86(3): 353-36410.1016/S0092-8674(00)80108-7Open DOISearch in Google Scholar

[34] HOOD JD, MEININGER CJ, ZICHE M, GRANGER HJ. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol 1998; 274(3 Pt 2): H1054-105810.1152/ajpheart.1998.274.3.H1054Search in Google Scholar

[35] HU Q, DEY AL, YANG Y, SHEN Y, JILANI IB, ESTEY EH, KANTARJIAN HM, GILES FJ, ALBITAR M. Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes. Cancer 2004; 100(9): 1884-1891.10.1002/cncr.20187Search in Google Scholar

[36] HURWITZ H, FEHRENBACHER L, NOVOTNY W, CARTWRIGHT T, HAINSWORTH J, HEIM W, BERLIN J, BARON A, GRIFFING S, HOLMGREN E, FERRARA N, FYFE G, ROGERS B, ROSS R, KABBINAVAR F. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350(23): 2335-2342.10.1056/NEJMoa032691Search in Google Scholar

[37] HUSSONG JW, RODGERS GM, SHAMI PJ. Evidence of increased angiogenesis in patients with acute myeloid leukemia. Blood 2000; 95(1): 309-313.10.1182/blood.V95.1.309Search in Google Scholar

[38] JERKIC M, RIVAS-ELENA JV, PRIETO M, CARRÓN R, SANZ-RODRÍGUEZ F, PÉREZBARRIOCANAL F, RODRÍGUEZ-BARBERO A, BERNABÉU C, LÓPEZ-NOVOA JM. Endoglin regulates nitric oxide-dependent vasodilatation. FASEB J 2004; 18(3): 609-611.10.1096/fj.03-0197fjeSearch in Google Scholar

[39] KEYHANI A, JENDIROBA DB, FREIREICH EJ. Angiogenesis and leukemia. Leuk Res 2001; 25(8): 639-645.10.1016/S0145-2126(00)00161-2Open DOISearch in Google Scholar

[40] KIVIVUORI SM, SIITONEN S, PORKKA K, VETTENRANTA K, ALITALO R, SAARINENPIHKALA U. Expression of vascular endothelial growth factor receptor 3 and Tie1 tyrosine kinase receptor on acute leukemia cells. Pediatr Blood Cancer 2007; 48(4): 387-392.10.1002/pbc.2085716685739Search in Google Scholar

[41] KOERSELMAN J, VAN DER GRAAF Y, DE JAEGERE PP, GROBBEE DE, Coronary collaterals: an important and underexposed aspect of coronary artery disease. Circulation 2003; 107(19): 2507-2511.10.1161/01.CIR.0000065118.99409.5F12756191Open DOISearch in Google Scholar

[42] KOOMAGI R, ZINTL F, SAUERBREY A, VOLM M. Vascular endothelial growth factor in newly diagnosed and recurrent childhood acute lymphoblastic leukemia as measured by real-time quantitative polymerase chain reaction. Clin Cancer Res 2001; 7(11): 3381-3384.Search in Google Scholar

[43] KUMAR S, GHELLAL A, LI C, BYRNE G, HABOUBI N, WANH JM, BUNDRED N. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 1999; 59(4): 856-861Search in Google Scholar

[44] LI C, ISSA R, KUMAR P, HAMPSON IN, LOPEZ-NOVOA JM, BERNABEU C, KUMAR S. CD105 prevents apoptosis in hypoxic endothelial cells. J Cell Sci 2003; 116 (Pt 13): 2677-2685.10.1242/jcs.0047012746487Search in Google Scholar

[45] LI DY, SORENSEN LK, BROOKE BS, URNESS LD, DAVIS EC, TAYLOR DG, BOAK BB, WENDEL DP. Defective angiogenesis in mice lacking endoglin. Science 1999; 284(5419): 1534-1537.10.1126/science.284.5419.153410348742Search in Google Scholar

[46] LI W, JI ZL, ZHUO GC, XU RJ, WANG J, JIANG HR. Effects of a selective cyclooxygenase-1 inhibitor in SKOV-3 ovarian carcinoma xenograft-bearing mice. Med Oncol 2010; 27(1): 98-10410.1007/s12032-009-9179-y19235530Open DOISearch in Google Scholar

[47] LIN RY, ARGENTA PA, SULLIVAN KM, ADZICK NS. Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients. Clin Cancer Res 1995; 1(3): 327-331.Search in Google Scholar

[48] LIU Y, JOVANOVIC B, PINS M, LEE C, BERGAN RC. Over expression of endoglin in human prostate cancer suppresses cell detachment, migration and invasion. Oncogene 2002; 21(54): 8272-8281.10.1038/sj.onc.1206117Open DOISearch in Google Scholar

[49] LUTTUN A, BRUSSELMANS K, FUKAO H. TJWA M, UESHIMA S, HERBERT JM, MATSUO O, COLLEN D, CARMELIET P, MOONS L. Loss of placental growth factor protects mice against vascular permeability in pathological conditions. Biochem Biophys Res Commun 2002; 295(2): 428-43410.1016/S0006-291X(02)00677-0Search in Google Scholar

[50] LYU CJ, RHA SY, WON SC. Clinical role of bone marrow angiogenesis in childhood acute lymphocytic leukemia. Yonsei Med J 2007; 48(2): 171-175.10.3349/ymj.2007.48.2.171Open DOISearch in Google Scholar

[51] MAEDA K, CHUNG YS, OGAWA Y, TAKATSUKA S, KANG SM, OGAWA M, SAWADA T, SOWA M. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996; 77(5): 858-863.10.1002/(SICI)1097-0142(19960301)77:5<858::AID-CNCR8>3.0.CO;2-AOpen DOISearch in Google Scholar

[52] MAGLIONE D, GUERRIERO V, VIGLIETTO G, DELLI-BOVI P, PERSICO MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A 1991; 88(20): 9267-9271.10.1073/pnas.88.20.9267Open DOISearch in Google Scholar

[53] MAGLIONE D, GUERRIERO V, VIGLIETTO G, FERRARO MG, APRELIKOVA O, ALITALO K, DEL VECCHIO S, LEI KJ, CHOU JY, PERSICO M.G. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 1993; 8(4): 925-931.Search in Google Scholar

[54] MAISONPIERRE PC, SURI C, JONES PF, BARTUNKOVA S, WIEGAND SJ, RADZIEJEWSKI C, COMPTON D, MCCLAIN J, ALDRICH TH, PAPADOPOULOS N, DALY TJ, DAVIS S, SATO TN, YANCOPOULOS GD. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277(5322): 55-60.10.1126/science.277.5322.55Search in Google Scholar

[55] MAKRILIA N, LAPPA T, XYLA V, NIKOLAIDIS I, SYRIGOS K. The role of angiogenesis in solid tumours: an overview. Eur J Intern Med 2009; 20(7): 663-671 10.1016/j.ejim.2009.07.009Open DOISearch in Google Scholar

[56] MIZIA-MALARZ A, SOBOL G, WOŚ H. Angiogeneza w przewlekłych schorzeniach zapalnych i nowotworowych. Pol Merk Lek 2008; XXIV, 141: 185-189Search in Google Scholar

[57] MURAKAMI M, MATSUMOTO R, URADE Y, AUSTEN KF, ARM JP. c-kit ligand mediates increased expression of cytosolic phospholipase A2, prostaglandin endoperoxide synthase-1, and hematopoietic prostaglandin D2 synthase and increased IgE-dependent prostaglandin D2 generation in immature mouse mast cells. J Biol Chem 1995; 270(7): 3239-3246. 10.1074/jbc.270.7.3239Search in Google Scholar

[58] MURPHY JF, FITZGERALD DJ. Vascular endothelial growth factor induces cyclooxygenasedependent proliferation of endothelial cells via the VEGF-2 receptor. FASEB J 2001; 15(9): 1667-1669.10.1096/fj.00-0757fjeSearch in Google Scholar

[59] NACOV E. Tumor angiogenesis formation of vessels de novo at germ cell tumors. Cancer 1990; 66(5): 916-922.10.1002/1097-0142(19900901)66:5<916::AID-CNCR2820660517>3.0.CO;2-MOpen DOISearch in Google Scholar

[60] NORÉN-NYSTRÖM U, HEYMAN M, FRISK P, GOLOVLEVA I, SUNDSTRÖM C, PORWIT A, ROOS G, BERGH A, FORESTIER E. Vascular density in childhood acute lymphoblastic leukemia correlates to biological factors and outcome. Br J Haematol 2009; 146(5): 521-53010.1111/j.1365-2141.2009.07796.xOpen DOISearch in Google Scholar

[61] OXMANN D, HELD-FEINDT J, STARK AM, HATTERMANN K, YONEDA T, MENTLEIN R. Endoglin expression in metastatic breast cancer cells enhances their invasive phenotype. Oncogene 2008; 27(25): 3567-3575.10.1038/sj.onc.1211025Open DOISearch in Google Scholar

[62] OZER E, SARIALIOGLU F, CETINGOZ R, YÜCEER N, CAKMAKCI H, OZKAL S, OLGUN N, UYSAL K, CORAPCIOGLU F, CANDA S. Prognostic significance of anaplasia and angiogenesis in childhood medulloblastoma: a pediatric oncology group study. Pathol Res Pract 2004; 200 (7-8): 501-509.10.1016/j.prp.2004.04.009Search in Google Scholar

[63] PADRO T, RUIZ S, BIEKER R, BÜRGER H, STEINS M, KIENAST J, BÜCHNER T, BERDEL WE, MESTERS RM. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia. Blood 2000; 95: 2637-2644.10.1182/blood.V95.8.2637Search in Google Scholar

[64] PEPPER MS, FERRARA N, ORCI L, MONTESANO R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991 Dec 16; 181(2): 902-90610.1016/0006-291X(91)91276-ISearch in Google Scholar

[65] PEREZ-ATAYDE AR, SALLAN SE, TEDROW U, CONNORS S, ALLRED E, FOLKMAN J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150(3): 815-821.Search in Google Scholar

[66] PERSICO MG, VINCENTI V, DIPALMA T. Structure, expression and receptor-binding properties of placenta growth factor (PlGF). Curr Top Microbiol Immunol 1999; 237: 31-40.10.1007/978-3-642-59953-8_2Search in Google Scholar

[67] PRICE DJ, MIRALEM T, JIANG S, STEINBERG R, AVRAHAM H. Role of vascular endothelial growth factor in the stimulation of cellular invasion and signaling of breast cancer cells. Cell Growth Differ 2001; 12(3): 129-135.Search in Google Scholar

[68] PULE MA, GULLMANN C, DENNIS D, MCMAHON C, JEFFERS M, SMITH OP. Increased angiogenesis in bone marrow of children with acute lymphoblastic leukemia has no prognostic significance. Br J Haematol 2002; 118(4): 991-998.10.1046/j.1365-2141.2002.03761.xOpen DOISearch in Google Scholar

[69] QU R, SILVER MM, LETARTE M. Distribution of endoglin in early human development reveals high levels on endocardial cushion tissue mesenchyme during valve formation. Cell Tissue Res 1998; 292(2): 333-343.10.1007/s004410051064Search in Google Scholar

[70] RADWAŃSKA U [red.] Białaczki u dzieci. Volumed, Wrocław ,1998: 17-89Search in Google Scholar

[71] RAK J, FILMUS J, KERBEL RS. Reciprocal paracrine interactions between tumour cells and endothelial cells: the 'angiogenesis progression' hypothesis. Eur J Cancer 1996; 32A(14): 2438-2450.10.1016/S0959-8049(96)00396-6Open DOISearch in Google Scholar

[72] RATAJCZAK MZ, RATAJCZAK J, MACHALINSKI B, MAJKA M, MARLICZ W, CARTER A, PIETRZKOWSKI Z, GEWIRTZ AM. Role of vascular endothelial growth factor (VEGF) and placenta-derived growth factor (PlGF) in regulating human haemopoietic cell growth. Br J Haematol 1998; 103(4): 969-979.10.1046/j.1365-2141.1998.01076.x9886308Open DOISearch in Google Scholar

[73] RISAU W, FLAMME I. Vasculogenesis. Annu Rev Cell Dev Biol 1995; 11: 73-91.10.1146/annurev.cb.11.110195.000445Open DOISearch in Google Scholar

[74] RISTIMÄKI A, NARKO K, ENHOLM B, JOUKOV V, ALITALO K. Proinflammatory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C. J Biol Chem 1998; 273(14): 8413-841810.1074/jbc.273.14.8413Search in Google Scholar

[75] SALES KJ, KATZ AA, HOWARD B, SOETERS RP, MILLAR RP, JABBOUR HN. Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, prostaglandin e receptors, and angiogenic factors by cyclooxygenase-1. Cancer Res 2002; 62(2): 424-432Search in Google Scholar

[76] SANO H, NOGUCHI T, MIYAJIMA A, HASHIMOTO Y, MIYACHI H. Anti-angiogenic activity of basic-type, selective cyclooxygenase (COX)-1 inhibitors. Bioorg Med Chem Lett 2006; 16(11): 3068-307210.1016/j.bmcl.2006.02.021Search in Google Scholar

[77] SATO N, BEITZ JG, KATO J, YAMAMOTO M, CLARK JW, CALABRESI P, RAYMOND A, FRACKELTON AR JR. Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol 1993;142(4):1119-1130.Search in Google Scholar

[78] SCHNEIDER N, LANZ S, RAMER R, SCHAEFER D, GOPPELT-STRUEBE M. Up-regulation of cyclooxygenase-1 in neuroblastoma cell lines by retinoic acid and corticosteroids. J Neurochem 2001; 77(2): 416-424.10.1046/j.1471-4159.2001.00264.xOpen DOISearch in Google Scholar

[79] SENGER DR, GALLI SJ, DVORAK AM, PERRUZZI CA, HARVEY VS, DVORAK HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 25;219(4587): 983-985.10.1126/science.6823562Search in Google Scholar

[80] SEO Y, BABA H, FUKUDA T, TAKASHIMA M, SUGIMACHI K. High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 2000; 88(10): 2239-2245.10.1002/(SICI)1097-0142(20000515)88:10<2239::AID-CNCR6>3.0.CO;2-VOpen DOISearch in Google Scholar

[81] SHIH TT, HOU HA, LIU CY, CHEN BB, TANG JL, CHEN HY, WEI SY, YAO M, HUANG SY, CHOU WC, HSU SC, TSAY W, YU CW, HSU CY, TIEN HF, YANG PC. Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival. Blood 2009; 113(14): 3161-7.10.1182/blood-2008-08-173104Open DOISearch in Google Scholar

[82] SIEGFRIED G, BASAK A, CROMLISH JA, BENJANNET S, MARCINKIEWICZ J, CHRÉTIEN M, SEIDAH NG, KHATIB AM. The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis. J Clin Invest 2003; 111(11): 1723-173210.1172/JCI200317220Open DOISearch in Google Scholar

[83] SKÖLDENBERG EG, CHRISTIANSSON J, SANDSTEDT B, LARSSON A, LÄCKGREN G, CHRISTOFFERSON R. Angiogenesis and angiogenic growth factors in Wilms tumor. J Urol 2001; 165 (6 Pt 2): 2274-2279.10.1016/S0022-5347(05)66183-6Search in Google Scholar

[84] SKÓRA J, BIEGUS J, PUPKA A, BARĆ P, SIKORA J, SZYBER P. Molekularne podstawy angiogenezy. Postepy Hig Med Dosw. (online), 2006; 60: 410-415Search in Google Scholar

[85] SMITH SK. Angiogenesis and implantation. Hum Reprod 2000; 15 Suppl 6: 59-66.Search in Google Scholar

[86] SMITH WL, DEWITT DL, GARAVITO RM. Cyclooxygenases: structural, cellular, and molecular biology. Annu Rev Biochem 2000; 69: 145-182.10.1146/annurev.biochem.69.1.145Open DOISearch in Google Scholar

[87] STACHEL D, ALBERT M, MEILBECK R, PAULIDES M, SCHMID I. Expression of angiogenic factors in childhood B-cell precursor acute lymphoblastic leukemia. Oncol Rep 2007; 17(1): 147-152.10.3892/or.17.1.147Search in Google Scholar

[88] STEWART M, TURLEY H, COOK N, PEZZELLA F, PILLAI G, OGILVIE D, CARTLIDGE S, PATERSON D, COPLEY C, KENDREW J, BARNES C, HARRIS AL, GATTER KC. The angiogenic receptor KDR is widely distributed in human tissues and tumours and relocates intracellularly on phosphorylation. An immunohistochemical study. Histopathology 2003; 43(1): 33-39.10.1046/j.1365-2559.2003.01644.xOpen DOISearch in Google Scholar

[89] ST-JACQUES S, FORTE M, LYE SJ, LETARTE M. Localization of endoglin, a transforming growth factor-beta binding protein, and of CD44 and integrins in placenta during the first trimester of pregnancy. Biol Reprod 1994; 51(3): 405-413.10.1095/biolreprod51.3.405Search in Google Scholar

[90] TAMMELA T, ENHOLM B, ALITALO K, PAAVONEN K. The biology of vascular endothelial growth factors. Cardiovasc Res 2005; 65(3): 550-56310.1016/j.cardiores.2004.12.002Open DOISearch in Google Scholar

[91] TANABE T, TOHNAI N. Cyclooxygenase isozymes and their gene structures and expression. Prostaglandins Other Lipid Mediat 2002; 68-69: 95-11410.1016/S0090-6980(02)00024-2Search in Google Scholar

[92] TSUJII M, KAWANO S, TSUJI S, SAWAOKA H, HORI M, DUBOIS RN. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 1998; 93(5): 705-716.10.1016/S0092-8674(00)81433-6Open DOISearch in Google Scholar

[93] VACCA A, RIBATTI D, IURLARO M, ALBINI A, MINISCHETTI M, BUSSOLINO F, PELLEGRINO A, RIA R, RUSNATI M, PRESTA M, VINCENTI V, PERSICO MG, DAMMACCO F. Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Int J Clin Lab Res 1998; 28(1): 55-68. 10.1007/s0059900500189594364Open DOISearch in Google Scholar

[94] VACCA A, RIBATTI D, RONCALI L, RANIERI G, SERIO G, SILVESTRIS F, DAMMACCO F. Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol 1994; 87(3): 503-508.10.1111/j.1365-2141.1994.tb08304.x7527645Open DOISearch in Google Scholar

[95] VAN ROYEN N, PIEK JJ, SCHAPER W, BODE C, BUSCHMANN I. Arteriogenesis: mechanisms and modulation of collateral artery development. J Nucl Cardiol 2001; 8(6): 687-693.10.1067/mnc.2001.11892411725265Open DOISearch in Google Scholar

[96] VIITA H, MARKKANEN J, ERIKSSON E, NURMINEN M, KINNUNEN K, BABU M, HEIKURA T, TURPEINEN S, LAIDINEN S, TAKALO T, YLA-HERTTUALA S. 15-lipoxygenase-1 prevents vascular endothelial growth factor A- and placental growth factorinduced angiogenic effects in rabbit skeletal muscles via reduction in growth factor mRNA levels, NO bioactivity, and downregulation of VEGF receptor 2 expression. Circ Res. 2008; 102(2): 177-184.10.1161/CIRCRESAHA.107.15555617991885Open DOISearch in Google Scholar

[97] WITTE MB, BARBUL A. General principles of wound healing. Surg Clin North Am 1997; 77(3): 509-528.10.1016/S0039-6109(05)70566-1Open DOISearch in Google Scholar

[98] XU L, COCHRAN DM, TONG RT, WINKLER F, KASHIWAGI S, JAIN RK, FUKUMURA D. Placenta growth factor overexpression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models. Cancer Res 2006; 66(8): 3971-3977.10.1158/0008-5472.CAN-04-3085Open DOISearch in Google Scholar

[99] YETGIN S, YENICESU I, CETIN M, TUNCER M. Clinical importance of serum vascular endothelial and basic fibroblast growth factors in children with acute lymphoblastic leukemia. Leuk Lymphoma 2001; 42(1-2): 83-88.10.3109/10428190109097679Open DOISearch in Google Scholar

[100] YOKOYAMA C, TANABE T. Cloning of human gene encoding prostaglandin endoperoxide synthase and primary structure of the enzyme. Biochem Biophys Res Commun 1989; 165(2): 888-894. 10.1016/S0006-291X(89)80049-XSearch in Google Scholar